Discontinuation of the concomitantly applied cytochrome P450 2D6 inhibitor may possibly lead to a lessen in codeine plasma focus and a rise in Energetic metabolite morphine plasma concentration which could raise or lengthen adverse reactions and should trigger most likely deadly respiratory depression.From Mayo Clinic for your inbox Join absolutely